| Tumor (n = 27) | Non-Tumor (n = 3) |
---|---|---|
Age, mean (SD) | 9.5 (5.5) | 6 (5.6) |
Range | 1–18 | 0–11 |
Sex n (%) | Â | Â |
Female | 12 (44) | 1 (33) |
Male | 15 (56) | 2 (67) |
Tumor type,a n (%) | Â | Â |
Embryonal | 6 (22) | Â |
Medulloblastoma | 4 | Â |
Embryonal (NOS) | 2 | Â |
Glioma | 13 (48) | Â |
Anaplastic ganglioglioma | 1 | Â |
Desmoplastic ganglioglioma | 2 | Â |
Dysembryoplastic neuroepithelial tumor | 2 | Â |
Dysplastic gangliocytoma | 1 | Â |
Glioblastoma | 1 | Â |
Pilocytic astrocytoma | 5 | Â |
Low-grade glioma | 1 | Â |
Ependymoma | 7 (30) | Â |
Subependymoma | 1 | Â |
Ependymoma | 5 | Â |
Myxopapillary ependymoma | 1 | Â |
WHO grade n (%) | Â | Â |
I | 12 (44) | Â |
II | 5 (19) | Â |
III | 2 (7) | Â |
IV | 8 (30) | Â |
Sample location n (%) | Â | Â |
Supratentorial | 9 (33) | 3 (100) |
Subtentorial | 17 (63) | Â |
Spinal | 1 (4) | Â |
Median follow up (years) | 14 | Â |
Mean time to recurrence (years) | 1.5 | Â |